Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


12.07.2021

2 Ann Neurol
1 Biochemistry (Mosc)
5 Mov Disord
1 Nat Rev Neurol
1 PLoS Comput Biol
1 PLoS One
2 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. LOESCH DP, Horimoto ARVR, Heilbron K, Sarihan EI, et al
    Characterizing the Genetic Architecture of Parkinson's Disease in Latinos.
    Ann Neurol. 2021 Jul 6. doi: 10.1002/ana.26153.
    PubMed         Abstract available

  2. WEISS D, Volkmann J, Fasano A, Kuhn A, et al
    Neurology Grand Rounds: Changing gears - DBS for dopaminergic desensitization in Parkinson's disease?
    Ann Neurol. 2021 Jul 7. doi: 10.1002/ana.26164.
    PubMed         Abstract available


    Biochemistry (Mosc)

  3. BUNEEVA OA, Medvedev AE
    DJ-1 Protein and Its Role in the Development of Parkinson's Disease: Studies on Experimental Models.
    Biochemistry (Mosc). 2021;86:627-640.
    PubMed         Abstract available


    Mov Disord

  4. FREIRE-ALVAREZ E, Kurca E, Lopez Manzanares L, Pekkonen E, et al
    Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial.
    Mov Disord. 2021 Jul 8. doi: 10.1002/mds.28703.
    PubMed         Abstract available

  5. CONCHA-MARAMBIO L, Farris CM, Holguin B, Ma Y, et al
    Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression.
    Mov Disord. 2021 Jul 8. doi: 10.1002/mds.28715.
    PubMed        

  6. SCHILLING M, Lill CM
    MicroRNAs as Molecular Biomarkers for Parkinson's Disease Progression.
    Mov Disord. 2021 Jul 5. doi: 10.1002/mds.28700.
    PubMed        

  7. GROS P, Wang X, Guan J, Lang AE, et al
    Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease.
    Mov Disord. 2021 Jul 9. doi: 10.1002/mds.28712.
    PubMed         Abstract available

  8. MULLER-NEDEBOCK AC, Komolafe MA, Fawale MB, Carr JA, et al
    Copy Number Variation in Parkinson's Disease: An Update from Sub-Saharan Africa.
    Mov Disord. 2021 Jul 6. doi: 10.1002/mds.28710.
    PubMed        


    Nat Rev Neurol

  9. CALDERON-GARCIDUENAS L
    Parkinson disease and air pollution: does what we breathe matter?
    Nat Rev Neurol. 2021 Jul 5. pii: 10.1038/s41582-021-00531.
    PubMed        


    PLoS Comput Biol

  10. DUCHET B, Ghezzi F, Weerasinghe G, Tinkhauser G, et al
    Average beta burst duration profiles provide a signature of dynamical changes between the ON and OFF medication states in Parkinson's disease.
    PLoS Comput Biol. 2021;17:e1009116.
    PubMed         Abstract available


    PLoS One

  11. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    PubMed         Abstract available


    Rev Neurol (Paris)

  12. AUBIGNAT M
    Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic.
    Rev Neurol (Paris). 2021 Jun 24. pii: S0035-3787(21)00584.
    PubMed        

  13. MARQUES A, Beze S, Lambert C, Bonamy L, et al
    Psycho-sensory modalities of visual hallucinations and illusions in Parkinson's disease.
    Rev Neurol (Paris). 2021 Jul 5. pii: S0035-3787(21)00590.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: